Cite

HARVARD Citation

    Cherqaoui, B. et al. (2018). Standard dose of Ustekinumab for childhood-onset deficiency of interleukin–36 receptor antagonist. Annals of the rheumatic diseases. 77 (12), p. e88. [Online]. 
  
Back to record